Plasma butylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys

Life Sciences

Volumn 59, Issue 11, 1996, Pages 939-943

  Carmona, G N ^a   Baum, I ^c   Schindler, C W ^a   Goldberg, S R ^a   Jufer, R ^a   Cone, E ^a   Slaughter, E ^b   Belendiuk, G W ^b   Gorelick, David A ^a,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Pharmavene Inc   (United States)

^c NONE

Author keywords

Butyrylcholinesterase; Cocaine; Rhesus monkeys; Squirrel monkey

Indexed keywords

BUTYRYLTHIOCHOLINE; CHOLINESTERASE; COCAINE;

AGE; ARTICLE; BODY WEIGHT; COLORIMETRY; CONTROLLED STUDY; DRUG HALF LIFE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; GAS CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RHESUS MONKEY; SPECIES DIFFERENCE; SQUIRREL MONKEY; ANIMAL; BLOOD; CEBIDAE; COMPARATIVE STUDY; HALF LIFE TIME; MACACA; MASS FRAGMENTOGRAPHY; METABOLISM;

ANIMALIA; MACACA MULATTA; PRIMATES; SAIMIRI; SCIURIDAE;

ANIMALS; BUTYRYLCHOLINESTERASE; BUTYRYLTHIOCHOLINE; COCAINE; COLORIMETRY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HALF-LIFE; MACACA MULATTA; MALE; SAIMIRI; SPECIES SPECIFICITY;

EID: 0029686495     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00392-X     Document Type: Article

References (21)

1. 1. D.J. STEWART, I. TADANOBU, B.K. TANG and KALOW, Life Sci. 20 1557-1564 (1977).
2. 2. R.S. HOFFMAN, G.L. HENRY, R.S. WEISMAN, M.S. HOWLAND and L.R. GODFRANK, Annal. Emerg. Med. 19 467 (1990).
3. 3. A. OM, S. ELLAHHAM, J.P. ORNATO, C. PICONE, J. THEOGARAJ, G.P. COORETJER and G.W. VETROVEC, Am. Heart. J. 125 1114 (1993).
4. 4. O. LOCKRIDGE, N.J. MOTTIERSHAW, H.W. ECKERSON and B. LADU, J. Pharmacol. Exp. Ther. 215 1-8 (1980).
5. 5. B. MENDAL and H. RUDNEY, J. Biochem. 43 59-63 (1953).
6. 6. J. MASSOULIE, L. PEZZEMENTI, S. NONE, E. KREJCI and F.M. VALLETTEE, Prog. Neurobio. 41 31-91 (1993).
7. 7. S.T. GEORGE and A.S. BALASUBRAMANIAN, Eur. J. Biochem. 121 177-186 (1981).
8. 8. M. VIGNY, V. GISIGER and J. MASSOULIE, Proc. Natl. Acad Sci. 75 2588-2592 (1978).
9. 9. B.N. LA DU, Trends. Pharmacol. Sci. 10 309-313 (1989).
10. 10. D. TRUNDLE and G. MARCIAL, Annal. Clin. Lab. Sci. 18 345-352 (1988).
11. 11. F.R. SIDELL and A. KAMINSKIS, Clin. Chem. 21 1393-1395 (1975).
12. 12. L. LEPAGE, F. SCHIELE, R. GUEGUEN and G. SIEST, Clin. Chem. 31 546-550 (1985).
13. 13. T. AOKI, N. TAKAYOSHI and S. HIROYASU, Comp. Biochem. 79C 325-329 (1984).
14. 14. A. PECK, Br. J. Pharmacol. 45 64-70 (1972).
15. 15. G.L. ELLMAN, K.D. COURTNEY, V. ANDRES and R.M. FEATHERSTONE, Biochem. Pharmacol. 7 88-95 (1961).
16. 16. E. J. CONE, M. HILLSGROVE and W. D. DARWIN, Clin. Chem. 40 1299-1305 (1994).
17. 17. K.W. LANKS and G.S. SKLAR, Anesthesiol. 44 428-430 (1976).
18. 18. J.M. TURNER, R.A. HALL, M. WHITTAKER and L.J. KRICKA, Ann. Clin. Biochem. 21 363-365 (1984).
19. 19. C. WASHINGTON, G. CARMONA, R. WOOSLEY, K. DRETCHEN, A. SINGH, G. BELENDIUK, I. MONTOYA, N. CARRIERO and D. GORELICK. NIDA Res. Monogr. 162 255 (1996).
20. 20. R.L. SMITH and R.T. WILLIAMS, J. Med. Prim. 8 138-152 (1974).
21. 21. A.W. BURG, R. BURROWS and C.J. KENSLER, Toxicol. Appl. Pharmacol. 28 162-166 (1974).